Lyell Immunopharma LYEL
NASDAQ LYEL
$9.79 +0.16 (+1.66%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lyell Immunopharma (LYEL) Total Non-Current Liabilities (2020 - 2026)

Updated

Lyell Immunopharma (LYEL) posted Total Non-Current Liabilities of $76.8 million for Q2 2026, down 5.2% from $81.01 million a year earlier but up 0.5% from the prior quarter.

Analysis

Lyell Immunopharma (LYEL) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Lyell Immunopharma's Total Non-Current Liabilities came in at $91.33 million, down 9.1% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -40.3% (FY2020 to FY2025).
  • In prior years, Lyell Immunopharma's Total Non-Current Liabilities was $100.44 million in FY2024 (+9.9%), $91.41 million in FY2023 (-8.8%), $100.2 million in FY2022 (-48.1%) and $193.05 million in FY2021 (-83.9%).
  • Quarterly Total Non-Current Liabilities has run from a low of $76.16 million in Q3 2025 to a high of $206.85 million in Q3 2021 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last six quarters, with an average decline of 5.1% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q4 2024, with growth of 9.9%; the weakest was Q4 2021, with a decline of 83.9%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $76.43 million (Q1 2026), $91.33 million (Q4 2025) and $76.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Lyell Immunopharma 229.06 Mn 229.06 Mn - 76.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 76.80 Mn
Mar 31, 2026 76.43 Mn
Dec 31, 2025 91.33 Mn
Sep 30, 2025 76.16 Mn
Jun 30, 2025 81.01 Mn
Mar 31, 2025 86.89 Mn
Dec 31, 2024 100.44 Mn
Sep 30, 2024 84.95 Mn
Jun 30, 2024 84.20 Mn
Mar 31, 2024 87.51 Mn
Dec 31, 2023 91.41 Mn
Sep 30, 2023 93.64 Mn
Jun 30, 2023 94.61 Mn
Mar 31, 2023 92.62 Mn
Dec 31, 2022 100.20 Mn
Sep 30, 2022 153.02 Mn
Jun 30, 2022 149.29 Mn
Mar 31, 2022 186.40 Mn
Dec 31, 2021 193.05 Mn
Sep 30, 2021 206.85 Mn
API Access

Lyell Immunopharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=LYEL&period=max&api_key=YOUR_API_KEY